Skip to content
Keangnam Korea Attends IMCAS Asia 2026 and Signs Strategic Partnership with Asterasys Korea
Keangnam Korea participated in IMCAS Asia 2026 in Bangkok and officially signed a strategic partnership with Asterasys Korea, strengthening international collaboration and advancing innovative aesthetic technologies for enhanced patient care.
A Journey of Global Connection and Advanced Aesthetic Innovation
In June 2026, the medical team and aesthetic experts from Keangnam Korea Aesthetic Clinic participated in IMCAS Asia 2026, one of Asia’s most prestigious international congresses in dermatology, aesthetic medicine, and plastic surgery, held in Bangkok, Thailand.
Bringing together thousands of physicians, industry experts, and leading aesthetic technology brands from around the world, IMCAS Asia serves as a global platform for scientific exchange, cutting-edge research, and the latest innovations shaping the future of aesthetic medicine.
For Keangnam Korea, attending IMCAS Asia 2026 was not only an opportunity to expand professional knowledge but also a valuable occasion to strengthen international partnerships and explore advanced technologies that can enhance treatment outcomes and patient experiences.
Continuously Updating Global Trends in Skin Rejuvenation and Aesthetic Technology
Throughout the congress, Keangnam Korea’s doctors and specialists attended numerous scientific sessions, workshops, and expert-led discussions focused on the latest developments in aesthetic medicine.
Key topics highlighted at IMCAS Asia 2026 included:
- Non-invasive skin tightening and facial rejuvenation technologies
- Next-generation anti-aging treatments
- Skin regeneration and restoration solutions
- Advanced RF and HIFU technologies
- Personalized treatment approaches
- AI-powered innovations in aesthetic medicine
By actively engaging in these educational opportunities, Keangnam Korea continues to strengthen its expertise and stay at the forefront of global aesthetic advancements, ensuring that patients benefit from modern, evidence-based treatment solutions.
A Major Milestone: Strategic Partnership Signing with Asterasys Korea
One of the most significant highlights of Keangnam Korea’s journey at IMCAS Asia 2026 was the official strategic partnership signing ceremony with Asterasys, a leading Korean medical aesthetic technology company recognized for its innovation in skin tightening, facial rejuvenation, and non-invasive treatment solutions.
Asterasys has established a strong international reputation through continuous research and development of advanced aesthetic technologies that are widely adopted by clinics and medical institutions worldwide.
The partnership signing ceremony, held during IMCAS Asia 2026, marks an important milestone in Keangnam Korea’s international development strategy and commitment to delivering world-class aesthetic services.
==> Read more: Keangnam Korea Expands International Collaboration with Italian Experts Following IMCAS Asia 2026
Expanding International Collaboration for Better Patient Outcomes
Through this strategic collaboration, Keangnam Korea aims to strengthen professional exchanges, gain access to emerging technologies, and expand training opportunities for its medical team.
The partnership also creates a solid foundation for introducing innovative treatment solutions and continuously enhancing service quality, allowing patients to experience advanced aesthetic procedures aligned with international standards.
As the global aesthetic industry evolves rapidly, partnerships with reputable international organizations play a crucial role in ensuring that patients receive safe, effective, and up-to-date treatment options.
A Commitment to Continuous Innovation
At Keangnam Korea, continuous learning, international collaboration, and technological advancement are fundamental to long-term growth and excellence in patient care.
Every international congress, educational program, and strategic partnership represents another step toward elevating professional standards and delivering exceptional aesthetic experiences.
The strategic partnership between Keangnam Korea and Asterasys at IMCAS Asia 2026 reflects a shared vision of innovation, excellence, and patient-centered care. It also reinforces Keangnam Korea’s commitment to bringing the latest global aesthetic technologies and medical expertise to clients seeking safe, modern, and effective beauty solutions.
RELATED ARTICLES
Collagen Injection vs. Laser for Facial Skin: Cost, Recovery, and Fit
A collagen injection vs laser for aging facial skin, which is better? They are two distinct approaches to facial rejuvenation and do not replace each other. Lasers work from the outside in to correct surface texture and pigment, while injected
Collagen Shots for the Face vs. Mesotherapy: Aging Grades, Cost, and Results
Deciding between collagen shots for the face and mesotherapy comes down to identifying which layer of your skin is experiencing aging. Mesotherapy nourishes the superficial skin layers for quick surface hydration, whereas collagen shots for the face rebuild structural density
How Long Does a Fox Eye Thread Lift Last? Costs, Risks, and Results
A fox eye thread lift is a minimally invasive procedure that uses dissolvable barbed threads to suspend the outer corner of the eye (lateral canthus) and the eyebrow tail toward the temple. By gently pulling these soft tissues upward, the
What Is a Liquid Nose Job? Cost, Longevity and When Do Threads Work Better?
What is a liquid nose job? A liquid nose job (clinically known as liquid rhinoplasty) is a non-surgical procedure that reshapes the nose using precision injections of hyaluronic acid (HA) filler. The treatment takes 10 to 15 minutes, requires zero
Semi-Structural Rhinoplasty for a Low Bridge and Wide Tip: Cost and Recovery
Semi-structural rhinoplasty is a targeted surgical procedure that reshapes specific portions of the nose, typically modifying a broad, rounded tip with autologous cartilage while elevating a slightly low bridge with a biocompatible implant. The procedure takes 45 to 90 minutes
Non-Surgical Rhinoplasty Price in 2026: Cost by Filler and Thread Type
The non-surgical rhinoplasty price in Ho Chi Minh City, Vietnam, ranges from $230 to $1,720 (6 to 45 million VND) per treatment in 2026. The overall cost is determined primarily by the specific material and technique selected: The material used
